4//SEC Filing
Harr Steve 4
Accession 0000899243-21-005738
CIK 0001770121other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:53 PM ET
Size
12.2 KB
Accession
0000899243-21-005738
Insider Transaction Report
Form 4
Harr Steve
DirectorPresident & CEO
Transactions
- Conversion
Common Stock
2021-02-08+2,031,250→ 8,173,750 total - Conversion
Series A-1 Convertible Preferred Stock
2021-02-08−1,075,000→ 0 total→ Common Stock (1,075,000 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−800,000→ 0 total→ Common Stock (800,000 underlying) - Conversion
Series B Convertible Preferred Stock
2021-02-08−156,250→ 0 total→ Common Stock (156,250 underlying)
Holdings
- 682,500(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
- [F2]The expiration date is not relevant to the conversion of these securities.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001627387
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:53 PM ET
- Size
- 12.2 KB